Abstract
We describe a patient with systemic lupus erythematosus (SLE) who exhibited severe cutaneous involvement characterized by the simultaneous presence of acute, subacute and discoid lesions in association with anti-S1 antibodies. After she failed to respond to chloroquine, medium to low dose steroids, steroid pulses, retinoids and cyclophosphamide, the patient was treated with Dapsone and a dramatic improvement in the cutaneous lesions was seen after only one month.
MeSH terms
-
Acute Disease
-
Adult
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Chronic Disease
-
Dapsone / therapeutic use*
-
Female
-
Humans
-
Lupus Erythematosus, Cutaneous / drug therapy*
-
Lupus Erythematosus, Cutaneous / pathology
-
Lupus Erythematosus, Discoid / drug therapy
-
Lupus Erythematosus, Discoid / pathology
-
Lupus Erythematosus, Systemic / drug therapy*
-
Lupus Erythematosus, Systemic / pathology
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Dapsone